de Hoyos-Parra R

Language: English
References: 16
Page: 167-169
PDF size: 142.07 Kb.

ABSTRACT

Non-communicable diseases are at the center of international consultation and there’s a general agreement on saying that several issues need to be solved before implementing prevention strategies and intervention programs. A sound knowledge of all the factors involved in the epidemic spread of a disease is the first target that has to be achieved in order to provide governments and policy makers with the best evidence-based conclusions. Present data are still too weak to gather solid decisions. Lack of standardized methods, common definitions or coherence with real life performances results therefore in conclusions that oscillate from one statement to its contrary. From this perspective, pediatricians and general practitioners are of great importance, being the direct link between the scientific community and children, having therefore the possibility to act at the first phases of obesity development, forging the best possible knowledge in order to transform prevention in the best possible cure.

REFERENCES

1. Koehlmoos TP. UN meeting for non-communicable diseases. BMJ 2011;343:d5762.

2. Suellentrop K, Morrow B, Williams L, D'Angelo D. Monitoring progress toward achieving Maternal and Infant Healthy People 2010 objectives--19 states, Pregnancy Risk Assessment Monitoring System (PRAMS), 2000- 2003. MMWR Surveill Summ 2006;55(9):1-11.

3. Rosenbaum SE, Glenton C, Wiysonge CS, Abalos E, Mignini L, Young T, et al. Evidence summaries tailored to health policy-makers in low- and middle-income countries. Bull World Health Organ 2011;89(1):54-61.

4. Hu FB. Resolved: there is sufficient scientific evidence that decreasing sugar-sweetened beverage consumption will reduce the prevalence of obesity and obesity-related diseases. Obes Rev 2013;14(8):606-619.

5. Malik VS, Schulze MB, Hu FB. Intake of sugar-sweetened beverages and weight gain: a systematic review. Am J Clin Nutr 2006;84(2):274-288.

6. Menachemi N, Tajeu G, Sen B, Ferdinand AO, Singleton C, Utley J, et al. Overstatement of results in the nutrition and obesity peer-reviewed literature. Am J Prev Med 2013;45(5):615-621.

7. Thomas O, Thabare L, Douketis J, Chu R, Westfall AO, Allison DB. Industry funding and the reporting quality of large long-term weight loss trials. Int J Obes (Lond) 2008;32(10):1531-1536.

8. Moise N, Cifuentes E, Orozco E, Willet W. Limiting the consumption of sugar sweetened beverages in Mexico’s obesogenic environment: a qualitative policy review and stakeholder analysis. J Public Health Policy 2011;32(4):458-475.

9. Phillips CM, Dillon C, Harrington JM, McCarthy VJ, Kearney PM, Fitzgerald AP, Perry IJ, et al. Defining metabolically healthy obesity: role of dietary and lifestyle factors. PLoS One 2013;8(10): e76188.

10. Gregori DC. Maffeis C. Snacking and obesity: urgency of a definition to explore such a relationship. J Am Diet Assoc 2007;107(4):562; discussion 562-3.

11. Farrell B, Kenyon S, Shakur H. Managing clinical trials. Trials 2010;11:78.

12. Beaglehole R, Bonita R, Alleyne G, Horton R, Li L, Lincoln P, et al. UN High-Level Meeting on Non-Communicable Diseases: addressing four questions. Lancet 2011;378(9789):449-455.

13. Kersh R, Stroup DF, Taylor WC. Childhood obesity: a framework for policy approaches and ethical considerations. Prev Chronic Dis 2011;8(5):A93.

14. Selassie M, Sinha AC. The epidemiology and aetiology of obesity: a global challenge. Best Pract Res Clin Anaesthesiol 2011;25(1):1-9.

15. Beaglehole R, Bonita R, Hurton R, Adams C, Alleyne G, Asaria P, et al. Priority actions for the non-communicable disease crisis. Lancet 2011;377(9775):1438-1447.

16. Alff F, Markert J, Zschaler S, Gausche R, Kiess W, Blüher S. Reasons for (non)participating in a telephone-based intervention program for families with overweight children. PLoS One 2012;7(4):e34580.